Michael G Grey - Net Worth and Insider Trading
Michael G Grey Net Worth
The estimated net worth of Michael G Grey is at least $21 Million dollars as of 2024-04-25. Michael G Grey is the Director of Mirum Pharmaceuticals Inc and owns about 382,948 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $9 Million. Michael G Grey is the Director of Horizon Therapeutics PLC and owns about 62,290 shares of Horizon Therapeutics PLC (HZNP) stock worth over $7 Million. Michael G Grey is also the Director of Biomarin Pharmaceutical Inc and owns about 42,840 shares of Biomarin Pharmaceutical Inc (BMRN) stock worth over $4 Million. Besides these, Michael G Grey also holds Mirati Therapeutics Inc (MRTX) . Details can be seen in Michael G Grey's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael G Grey has not made any transactions after 2023-09-14 and currently still holds the listed stock(s).
Transaction Summary of Michael G Grey
Michael G Grey Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael G Grey owns 7 companies in total, including Spruce Biosciences Inc (SPRB) , Horizon Therapeutics PLC (HZNP) , and Biomarin Pharmaceutical Inc (BMRN) among others .
Click here to see the complete history of Michael G Grey’s form 4 insider trades.
Insider Ownership Summary of Michael G Grey
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SPRB | Spruce Biosciences Inc | 2020-10-08 | director & Executive Chairman |
HZNP | Horizon Therapeutics PLC | 2021-07-22 | director |
BMRN | Biomarin Pharmaceutical Inc | 2021-03-05 | director |
MIRM | Mirum Pharmaceuticals Inc | 2023-09-14 | director & Executive Chairman |
MRTX | Mirati Therapeutics Inc | 2020-12-14 | director |
ACHN | Achillion Pharmaceuticals Inc | 2009-12-18 | director |
RPHM | Reneo Pharmaceuticals Inc | 2021-04-08 | director & Executive Chairman |
Michael G Grey Latest Holdings Summary
Michael G Grey currently owns a total of 4 stocks. Among these stocks, Michael G Grey owns 382,948 shares of Mirum Pharmaceuticals Inc (MIRM) as of September 14, 2023, with a value of $9 Million and a weighting of 44.65%. Michael G Grey owns 62,290 shares of Horizon Therapeutics PLC (HZNP) as of July 22, 2021, with a value of $7 Million and a weighting of 35.17%. Michael G Grey also owns 42,840 shares of Biomarin Pharmaceutical Inc (BMRN) as of March 5, 2021, with a value of $4 Million and a weighting of 18.97%. The other 1 stocks Mirati Therapeutics Inc (MRTX) have a combined weighting of 1.21% among all his current holdings.
Latest Holdings of Michael G Grey
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MIRM | Mirum Pharmaceuticals Inc | 2023-09-14 | 382,948 | 24.02 | 9,198,411 |
HZNP | Horizon Therapeutics PLC | 2021-07-22 | 62,290 | 116.30 | 7,244,327 |
BMRN | Biomarin Pharmaceutical Inc | 2021-03-05 | 42,840 | 91.20 | 3,907,008 |
MRTX | Mirati Therapeutics Inc | 2020-12-14 | 4,256 | 58.70 | 249,827 |
Holding Weightings of Michael G Grey
Michael G Grey Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael G Grey has made a total of 3 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Mirum Pharmaceuticals Inc is the sale of 14,608 shares on September 14, 2023, which brought Michael G Grey around $467,456.
According to the SEC Form 4 filings, Michael G Grey has made a total of 6 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Horizon Therapeutics PLC is the sale of 5,000 shares on July 22, 2021, which brought Michael G Grey around $500,200.
According to the SEC Form 4 filings, Michael G Grey has made a total of 2 transactions in Biomarin Pharmaceutical Inc (BMRN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Biomarin Pharmaceutical Inc is the sale of 5,000 shares on March 5, 2021, which brought Michael G Grey around $381,400.
More details on Michael G Grey's insider transactions can be found in the Insider Trading History of Michael G Grey table.Insider Trading History of Michael G Grey
- 1
Michael G Grey Trading Performance
GuruFocus tracks the stock performance after each of Michael G Grey's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael G Grey is 19.59%. GuruFocus also compares Michael G Grey's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael G Grey within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael G Grey's insider trading performs compared to the benchmark.
Performance of Michael G Grey
Average Return
42.28%
Outperforming Transactions
100%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 16.06 | 19.59 | 40.62 | 42.28 | 70.49 | 65.19 |
Relative Return to S&P 500(%) | 14.72 | 17.98 | 33.01 | 28.8 | 60.91 | 58.3 |
Michael G Grey Ownership Network
Ownership Network List of Michael G Grey
Ownership Network Relation of Michael G Grey
Michael G Grey Owned Company Details
What does Spruce Biosciences Inc do?
Who are the key executives at Spruce Biosciences Inc?
Michael G Grey is the director & Executive Chairman of Spruce Biosciences Inc. Other key executives at Spruce Biosciences Inc include 10 percent owner Novo Holdings A/s , Chief Medical Officer Charlton Ralph William Iii , and director & Chief Executive Officer Javier B. Szwarcberg .
Spruce Biosciences Inc (SPRB) Insider Trades Summary
Over the past 18 months, Michael G Grey made no insider transaction in Spruce Biosciences Inc (SPRB). Other recent insider transactions involving Spruce Biosciences Inc (SPRB) include a net sale of 1,964,336 shares made by Novo Holdings A/s , and a net purchase of 630,400 shares made by Niall O'donnell .
In summary, during the past 3 months, insiders sold 4,172,336 shares of Spruce Biosciences Inc (SPRB) in total and bought 0 shares, with a net sale of 4,172,336 shares. During the past 18 months, 4,172,336 shares of Spruce Biosciences Inc (SPRB) were sold and 2,838,400 shares were bought by its insiders, resulting in a net sale of 1,333,936 shares.
Spruce Biosciences Inc (SPRB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spruce Biosciences Inc Insider Transactions
Michael G Grey Mailing Address
Above is the net worth, insider trading, and ownership report for Michael G Grey. You might contact Michael G Grey via mailing address: C/o Sgx Pharmaceuticals, Inc., 10505 Roselle Street, San Diego Ca 92121.